The global bioresorbable polymers market is valued at USD 500.0 million in 2024 and is projected to reach USD 867.2 million by 2029, growing at 11.6% cagr from 2024 to 2029. This market research report provides access to critical information such as bioresorbable polymers market growth drivers, market growth restraints, current market trends, the market’s economic and financial structure, and other key market details. The drug delivery segment is the rapidly growing segment for bioresorbable polymers market. The growth is driven by the high demand of oral capsules. Such polymers have long been employed in the design of implantable matrices for effective drug delivery, especially after encapsulation; nontoxicity associated with such absorption makes these systems safe and convenient. Bioresorbable polymers are helping FDA-approved drugs attain better pharmacokinetics by releasing the prescribed drug dosage in a sustained manner, thus eliminating multiple injections or surgical means of drug delivery. These polymers integrate out of function and are absorbed into the body after their use, making it more comfortable and favorable for patients to use, which is driving demand in this segment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=235258717
Orthopedic devices segment is estimated to be the largest application segment of bioresorbable polymers market, in terms of value, during the forecast period.
The orthopedic devices segment is anticipated to be the largest application of bioresorbable polymers market, mainly due to the prevalent use in the treatment for trauma, hip, knee, spine, and sports injuries. Bioresorbable polymers possess ideal properties for orthopedic applications: gradual degradation and absorption within the body that avoids device removal surgeries. This property is of special significance in orthopedic applications, including bone fixation, joint repair, and spinal procedures in which materials that are strong yet bioresorbable sustain the healing process. Demand for such state-of-the-art, patient-friendly materials for orthopedic therapies has spurred growth in this application segment.
PLA by type is estimated to be the largest type of bioresorbable polymers market, in terms of value, during the forecast period.
The PLA type segment is estimated to be largest type segment in the bioresorbable polymers market, in terms of value, during the forecast period. PLA has been of great use in orthopedic devices and drug delivery systems because of its biodegradability and bioresorbability. Use of PLA-based bioresorbable implants offers temporary structural support in orthopedic applications, allowing natural tissue regeneration to occur and thus eliminating the necessity of removal surgically. In drug delivery, PLA is used in controlled release systems, where it enables the precise delivery of medication directly to the body and eventually dissolves without leaving residues. With compatibility of PLA to human tissue and the possibility of engineering it to suit specific medical purposes, this material also supports the wide use in healthcare settings as the need grows for patient-centered, minimally invasive solutions. This growth is further driven by increasing medical awareness and government support for advanced biocompatible materials.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235258717
South America is projected to register the second highest CAGR, in terms of value, during the forecast period in the bioresorbable polymers market.
South America is projected to register the second highest CAGR in the bioresorbable polymers market, in terms of value, during forecast period due to several factors. Continued research and development in manufacturing technology in the South American market influences the bioresorbable polymers market. Innovative solutions that increase functionality, reduce costs, and improve product quality must be developed as industries involve. This includes developments in medical device manufacturing techniques and new materials, such as biocompatible polymers.
Bioresorbable Polymers Companies
The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235258717
Corbion is a global leader in sustainable food ingredients, biochemicals and bio-based solutions focused on lactic acid and its derivatives. Their areas of expertise lie in bioresorbable polymers, which are added extensively in medical products like drug delivery systems, sutures and tissue engineering. This helps optimize patient outcomes, as Corbion's bioresorbable polymers provide safe and reliable biodegradability in a range of medical and pharmaceutical applications. Corbion creates leading health, wellness, and eco-friendly solutions for various industries through a focus on innovation and sustainability.
Evonik is one of the global leaders in specialty chemicals that strives to provide sustainable, tailored solutions for its customers across sectors. Evonik is a leader in bioresorbable polymers for medical applications like implantable devices, drug delivery systems and tissue engineering. The bioresorbable polymers by them have designed degradation rates, and biocompatibility that translate to better patient care and less environmental impact. Evonik never stops innovating, providing new methods and approaches that will drive innovation in high-performance medical technologies for better safety and efficacy.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/bioresorbable-polymer-market-235258717.html
